Methods and devices for endovascular ablation of a splanchnic nerve
Systems, devices, and methods for transvascular ablation of target tissue. The devices and methods may, in some examples, be used for splanchnic nerve ablation to increase splanchnic venous blood capacitance to treat at least one of heart failure and hypertension. For example, the devices disclosed herein may be advanced endovascularly to a target vessel in the region of a thoracic splanchnic nerve (TSN), such as a greater splanchnic nerve (GSN) or a TSN nerve root. Also disclosed are method of treating heart failure, such as HFpEF, by endovascularly ablating a thoracic splanchnic nerve to increase venous capacitance and reduce pulmonary blood pressure.
1. A method of ablating a greater splanchnic nerve or a greater splanchnic nerve root to increase splanchnic venous blood capacitance, comprising:
advancing an elongate medical device into an azygos vein, the elongate medical device including a distal region and an ablation element disposed at the distal region;
advancing the ablation element from the azygos vein into a T9, T10, or T11 intercostal vein;
when the ablation element is disposed in the T9, T10, or T11 intercostal vein, delivering energy from the ablation element; and
creating a lesion having a length in a range of 5 to 20 mm,
whereby creating the lesion ablates a portion of the greater splanchnic nerve or the greater splanchnic nerve root.
2. The method of claim 1 , wherein the elongate medical device comprises a fluid lumen and the distal region includes an inflatable membrane, the method further comprising delivering a fluid through the fluid lumen and into inflatable membrane to thereby inflate the inflatable membrane to an expanded configuration.
3. The method of claim 1 , wherein creating the lesion having a length in a range of 5 to 20 mm comprises creating a continuous circumferential lesion having a length in a range of 5 to 20 mm.
4. The method of claim 1 , wherein creating the lesion comprises creating a lesion that has a depth of at least 5 mm.
5. The method of claim 1 , wherein advancing the ablation element from the azygos vein into the T9, T10, or T11 intercostal vein comprises maintaining a position of the ablation element from an ostium of the azygos vein to the intercostal vein to up to 20 mm from the ostium.
6. The method of claim 1 , wherein advancing the ablation element from the azygos vein into the T9, T10, or T11 intercostal vein comprises maintaining a position of the ablation element from an ostium of the azygos vein to the intercostal vein to up to 15 mm from the ostium.
7. The method of claim 1 , wherein advancing the ablation element from the azygos vein into the T9, T10, or T11 intercostal vein comprises advancing the ablation element from the azygous vein into the T11 intercostal vein.
8. The method of claim 7 , further comprising performing an ablation confirmation test, and repositioning the ablation element into the T10 intercostal vein and delivering energy from the ablation element.
9. The method of claim 7 , further comprising performing an ablation confirmation test, and repositioning the ablation element into the T9 intercostal vein and delivering energy from the ablation element.
10. The method of claim 1 , further comprising, prior to delivering the energy, delivering stimulation energy to first and second stimulation electrodes carried by the medical device to determine if the ablation element is in a target location within the intercostal vein.
11. The method of claim 1 , wherein delivering energy comprises delivering energy from less than 100% of a circumference of the ablation element.
12. The method of claim 11 , wherein delivering energy comprises delivering energy from less than 50% of the circumference of the ablation element.